Evidence map›Paper›PMID 38023174›Full record

ArticleFrontiers in oncology2023

Subpopulation treatment effect pattern plot analysis: a prognostic model for distant recurrence-free survival to estimate delayed adjuvant chemotherapy initiation effect in triple-negative breast cancer.

Zaida Morante, Yomali Ferreyra, Joseph A Pinto, Natalia Valdivieso, Carlos Castañeda, Tatiana Vidaurre, Guillermo Valencia, Patricia Rioja, Hugo Fuentes, José M Cotrina and 2 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zaida MoranteDepartamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Yomali FerreyraDepartamento de Bioingeniería, Universidad de Ingeniería y Tecnología, Lima, Peru.
Joseph A PintoCentro de Investigación Básica y traslacional, Auna Ideas, Lima, Peru.
Natalia ValdiviesoDepartamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Carlos CastañedaDepartamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Tatiana VidaurreDepartamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Guillermo ValenciaDepartamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Patricia RiojaDepartamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Hugo FuentesDepartamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
José M CotrinaDepartamento de Cirugía en Mamas y Tejidos Blandos, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Silvia NeciosupDepartamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Henry L GomezOncosalud, AUNA, Lima, Peru.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Triple-negative breast cancer (TNBC) is a heterogeneous disease associated with a poor prognosis. Delaying in time to start adjuvant chemotherapy (TTC) has been related to an increased risk of distant recurrence-free survival (DRFS). We aimed to develop a prognostic model to estimate the effects of delayed TTC among TNBC risk subgroups. Materials and methods: We analyzed 687 TNBC patients who received adjuvant chemotherapy at the Instituto Nacional de Enfermedades Neoplasicas (Lima, Peru). Database was randomly divided to create a discovery set (n=344) and a validation set (n=343). Univariate and multivariate Cox regression models were performed to identify prognostic factors for DRFS. Risk stratification was implemented through two models developed based on proportional hazard ratios from significant clinicopathological characteristics. Subpopulation treatment effect pattern plot (STEPP) analysis was performed to determine the best prognostic cut-off points for stratifying TNBC subgroups according to risk scores and estimate Kaplan-Meier differences in 10-year DRFS comparing TTC (≤30 vs.>30 days). Results: In univariate analysis, patients aged ≥70 years (HR=4.65; 95% CI: 2.32-9.34; p=<0.001), those at stages pT3-T4 (HR=3.28; 95% CI: 1.57-6.83; p=0.002), and pN2-N3 (HR=3.00; 95% CI: 1.90-4.76; p=<0.001) were notably associated with higher risk. STEPP analysis defined three risk subgroups for each model. Model N°01 categorized patients into low (score: 0-31), intermediate (score:32-64), and high-risk (score: 65-100) cohorts; meanwhile, Model N°02: low (score: 0-26), intermediate (score: 27-55), and high (score: 56-100). Kaplan-Meier plots showed that in the discovery set, patients with TTC>30 days experienced a 17.5% decrease in 10-year DRFS rate (95%CI=6.7-28.3), and the impact was more remarkable in patients who belong to the high-risk subgroup (53.3% decrease in 10 years-DRFS rate). Similar results were found in the validation set. Conclusions: We developed two prognostic models based on age, pT, and pN to select the best one to classify TNBC. For Model N°02, delayed adjuvant chemotherapy conferred a higher risk of relapse in patients ≥70 years and who were characterized by pT3/T4 and pN2/N3. Thus, more efforts should be considered to avoid delayed TTC in TNBC patients, especially those in high-risk subgroups.

Indexed as

adjuvant chemotherapybreast cancerprognostic factor analysissubpopulation treatment effect pattern plottriple negative breast cancer

Identifiers

PMID38023174
PMCPMC10657890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.